non fda approved glp 1 says that the GLP-1 shortage is over FDA moves to crack down

Fatigue, headaches, muscle cramps, and worsened nausea are common signs of electrolyte depletion

doi: 10.1016/j.diabet.2019.101117 148 CampbellJEUssherJRMulvihillEEKolicJBaggioLLCaoXet al

But in March 2024, the US Food and Drug Administration expanded the indication of the peptide to help obese people lose weight and reduce the risk of cardiovascular incidents

GLP-1RAs work by increasing the levels of the hormone glucagon-like peptide-1 (GLP-1) in the body

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a group of oral hypoglycemic agents used to manage Type 2 Diabetes Mellitus, which is a significant risk factor for coronary disease, heart failure, stroke, and many other cardiovascular conditions